Head and Neck

Head & Neck Cancer Treatment Trials

Protocol
Number

Title

ID

SLUHN 2013-53

A Phase 1 Dose Escalation Study of GC4419 in Combination With Radiation and Chemotherapy for Squamous Cell Cancers of the Head and Neck

Learn more.

NCT01921426
SLUHN 2013 -78

A Randomized, Double-Blind, Placebo-Controlled Study of Chemotherapy Plus Cetuximab in Combination With VTX 2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Learn more.

NCT01836029
SLUHN 2015-16

A Phase 3 Clinical Trial of Pembrolizumab (MK-3475) in First Line Treatment of recurrent/Metastatic Head & Neck

Learn more.

NCT02358031